Related Experiment Videos
Genetics in urogenital cancer
The Urologic Clinics of North America
|October 1, 1980
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Current status of prophylactic surgery for hereditary breast and gynecologic cancers.
Current opinion in obstetrics & gynecology·2001
Parental communication of BRCA1/2 genetic test results to children.
Patient education and counseling·2001
E-cadherin mutation-based genetic counseling and hereditary diffuse gastric carcinoma.
Cancer genetics and cytogenetics·2000
Anticipation in familial Hodgkin's lymphoma.
Human genetics·2000
Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling.
American journal of human genetics·2000
Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.
The Urologic clinics of North America·2026
Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.
The Urologic clinics of North America·2026
Economic Considerations in the Management of Superficial Bladder Cancer.
The Urologic clinics of North America·2026
Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.
The Urologic clinics of North America·2026
Impact of Social and Structural Determinants of Health on Bladder Cancer Outcomes: Focus on Non-Muscle-Invasive Disease.
The Urologic clinics of North America·2026
Surveillance Protocols: Balancing Patient Burden and Cancer Control.
The Urologic clinics of North America·2026
Identifying the Potential Role of Missense KIRREL3 Variants in Neurodevelopmental Phenotypes: A Case Series.
American journal of medical genetics. Part A·2026
Delineating the CTBP1-Related Phenotypic Spectrum: A Review of HADDTS and Atypical Variants.
International journal of molecular sciences·2026
Association Study Between NOTCH2 Gene and Idiopathic Central Precocious Puberty in Korean Girls.
International journal of molecular sciences·2026
Ultrasound-guided renal artery administration of angiopoietin-1 RNA therapy slows the progression of preclinical WT1 glomerular disease.
Science translational medicine·2026